Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00029211 · ClinicalTrials.gov registry record · Phase 3
A Trial of Echinacea in Children
A Phase 3 study, sponsored by National Center for Complementary and Integrative Health (NCCIH).
- Completed
- Registry status
- Phase 3
- Development phase
- 600
- Enrollment target
NCT00029211 is a Phase 3 study that has completed, run by National Center for Complementary and Integrative Health (NCCIH). The registered enrollment target is 600 participants.
The verdict
NCT00029211, a Phase 3 study, has completed, sponsored by National Center for Complementary and Integrative Health (NCCIH).
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 600 participants
- Enrollment target
Study Summary
This is a randomized trial to determine if echinacea is effective in shortening the length and/or lessening the severity of colds in children 2 through 11 years old.
Interventions
- DRUG Echinacea
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 600 participants |
| Start Date | 2000-04 |
| Est. Completion | 2003-03 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00029211
The ClinicalTrials.gov registry entry for NCT00029211 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 600 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Center for Complementary and Integrative Health (NCCIH), which has 203 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Echinacea is the first listed.
NCT00029211 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00029211 about?
NCT00029211 is a clinical study titled "A Trial of Echinacea in Children". This is a randomized trial to determine if echinacea is effective in shortening the length and/or lessening the severity of colds in children 2 through 11 years old.
What is the current status of trial NCT00029211?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 600 participants. The study started on 2000-04. Estimated completion is 2003-03.
What interventions are being tested in trial NCT00029211?
The interventions under investigation include: Echinacea (DRUG).
Who is sponsoring clinical trial NCT00029211?
This trial is sponsored by National Center for Complementary and Integrative Health (NCCIH), which has 203 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.